First US Service Members Treated with the Only FDA-Approved Cross-Linking Procedure in the U.S.

WALTHAM, Mass.--(BUSINESS WIRE)--#avedro--Avedro, Inc., an ophthalmic pharmaceutical and medical device company, has begun selling Photrexa Viscous® (riboflavin 5-‘phosphate in 20% dextran ophthalmic solution), Photrexa® (riboflavin 5’-phosphate ophthalmic solution) and the KXL® System to key military hospitals around the country. Fort Belvoir Hospital, located in Fort Belvoir, VA, made history on November 21st to become the first military facility in the country to perform FDA-approved corneal cross-li